# Zenith® Fenestrated+ Clinical Study

Study · id `cardio:ct-nct04875429` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04875429](<https://clinicaltrials.gov/study/NCT04875429>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04875429

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 105 participants.

## Technical summary

Registry record NCT04875429. Allocation not applicable; no masking; primary purpose treatment. Start 2023-12-08 (actual); primary completion 2026-11 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 105 participants (planned count; ClinicalTrials.gov record NCT04875429, source copy `cardio:ctgov-nct04875429-2026-10-06`, retrieved 2026-11-18)
- Started: 2023-12-08 (actual) (ClinicalTrials.gov record NCT04875429, source copy `cardio:ctgov-nct04875429-2026-10-06`, retrieved 2026-11-18)
- Primary completion: 2026-11 (anticipated) (ClinicalTrials.gov record NCT04875429, source copy `cardio:ctgov-nct04875429-2026-10-06`, retrieved 2026-11-18)
- Completion: 2031-11 (anticipated) (ClinicalTrials.gov record NCT04875429, source copy `cardio:ctgov-nct04875429-2026-10-06`, retrieved 2026-11-18)
- Countries: United States; United Kingdom (ClinicalTrials.gov record NCT04875429, source copy `cardio:ctgov-nct04875429-2026-10-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04875429-2026-10-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: Zenith® Fenestrated+ Clinical Study
- Condition: Aortic Aneurysm, Abdominal
- Condition: Juxtarenal Aortic Aneurysm
- Condition: Extent IV Thoracoabdominal
- Condition: Pararenal Aneurysm
- Intervention (Device): Zenith Fenestrated+ Endovascular Graft in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System and Unibody2
- Lead sponsor: Cook Research Incorporated
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Cook Research Incorporated (`cardio:org-cook-research-incorporated`)

## Provenance

Content hash: 0fb9a758fe2e4cfdb4ecb2527a47fc3f306125e6ecb0be279b766dfe61e27324
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
